Rchr
J-GLOBAL ID:200901008575762386
Update date: Sep. 22, 2022
Miyakawa Toshikazu
ミヤカワ トシカズ | Miyakawa Toshikazu
Affiliation and department:
Kumamoto University University Hospital, ,University Hospital ,Kumamoto University
About Kumamoto University University Hospital, ,University Hospital ,Kumamoto University
Search "Kumamoto University University Hospital, ,University Hospital ,Kumamoto University"
Detailed information
Job title:
Assistant Professor
Papers (10):
Yoshitaka Kikukawa, Hiromichi Yuki, Sinya Hirata, Kazuhiko Ide, Hirotomo Nakata, Toshikazu Miyakawa, Naofumi Matsuno, Kisato Nosaka, Yuji Yonemura, Tatsuya Kawaguchi, et al. Combined use of bortezomib, cyclophosphamide, and dexamethasone induces favorable hematological and organ responses in Japanese patients with amyloid light-chain amyloidosis: a single-institution retrospective study. INTERNATIONAL JOURNAL OF HEMATOLOGY. 2015. 101. 2. 133-139
Yuri Miyazaki, Kazuaki Taguchi, Keitaro Sou, Hiroshi Watanabe, Yu Ishima, Toshikazu Miyakawa, Hiroaki Mitsuya, Masafumi Fukagawa, Masaki Otagiri, Toru Maruyama. Therapeutic Impact of Erythropoietin-Encapsulated Liposomes Targeted to Bone Marrow on Renal Anemia. MOLECULAR PHARMACEUTICS. 2014. 11. 11. 4238-4248
Kazuaki Taguchi, Toshikazu Miyakawa, Takafumi Ohmura, Momoko Horio, Yoshihisa Anraku, Tatsuya Okada, Hiroshi Mizuta, Hideyuki Saito, Tatsuya Kawaguchi. A reduced linezolid dosage maintains favorable efficacy with minimal hematologic toxicity in a methicillin-resistant Staphylococcus aureus-infected patient with renal insufficiency. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2013. 45. 1. 77-80
Takeshi Nishijima, Hiroyuki Gatanaga, Takuro Shimbo, Hirokazu Komatsu, Tomoyuki Endo, Masahide Horiba, Michiko Koga, Toshio Naito, Ichiro Itoda, Masanori Tei, et al. Switching tenofovir/emtricitabine plus lopinavir/r to raltegravir plus Darunavir/r in patients with suppressed viral load did not result in improvement of renal function but could sustain viral suppression: a randomized multicenter trial. PloS one. 2013. 8. 8. e73639
Hirokazu Nagai, Takashi Odawara, Atsushi Ajisawa, Shotaro Hagiwara, Tomoyuki Watanabe, Tomoko Uehira, Hideki Uchiumi, Mihoko Yotsumoto, Toshikazu Miyakawa, Akira Watanabe, et al. Whole brain radiation alone produces favourable outcomes for AIDS-related primary central nervous system lymphoma in the HAART era. EUROPEAN JOURNAL OF HAEMATOLOGY. 2010. 84. 6. 499-505
more...
MISC (27):
YAMAMOTO Keiichi, OHKUMA Masanori, IKEDA Katsuyoshi, OBAYASHI Konen, ANDO Yukio, FUJIMOTO Yoko, TEDUKA Mina, MIYAKAWA Toshikazu, KAWAGUCHI Tatsuya. Cost-Effective Optimization of Surveillance Cultures for MRSA in the Neonatal Intensive Care Unit at a University Hospital. Environmental Infections. 2015. 30. 5. 331-335
立川 夏夫, 照屋 勝治, 宮川 寿一. Q&A形式Case study ニューモシスチス肺炎とHIV感染症を合併した症例. HIV感染症とAIDSの治療. 2014. 5. 1. 35-41
宮川 寿一. PHOTO QUIZ 咳嗽,発熱,倦怠感があり,CT検査にて肺野の多発結節影,腹部リンパ節腫脹,脾腫を認めた症例。診断は?. HIV感染症とAIDSの治療. 2014. 5. 2. 70-73
田上 直美, 松下 修三, 友枝 沙紀, 財津 和宏, 満屋 裕明, 齋藤 秀之, 市川 康子, 嘉村 基樹, 下村 光一, 中村 嘉久太, et al. 28-P4AM-153 地方自治体と協働した針刺し切創・皮膚粘膜曝露後の抗HIV薬提供体制と地域医療連携による運用改善(感染制御(その他)2,一般演題(ポスター),新時代を拓く医療薬学フロンティア). 日本医療薬学会年会講演要旨集. 2014. 24. 0. 400-400
宮川 寿一, 満屋 裕明. 病気について知りたい! 臨床講座(41)HIV感染症. Pharma tribune : なりたい薬剤師になる!. 2012. 4. 5. 61-72
more...
Works (5):
新規抗HIV剤の感受性に与えるケモカイン・ケモカインレセプターの多様性の検討
2005 - 2007
HIV感染症での血液幹細胞異常と新規抗HIV剤の影響の解析と対応策の研究・開発
2005 - 2006
新規のCCR5阻害剤の同定・開発とCCR5を介したHIV感染の分子機構の解明
2004 - 2005
耐「薬剤耐性」プロテアーゼ阻害剤(抗HIV剤)の基礎研究と開発
2003 - 2005
CCR5を標的とした新規の抗HIV剤の基礎的研究と開発
2003 - 2004
Education (4):
- 2002 Kumamoto University
- 2002 Kumamoto University Graduate School, Division of Medicine
- 1995 Kumamoto University School of Medicine School of Medicine
- 1995 Kumamoto University Faculty of Medicine
Professional career (1):
Doctor of Medicine (Kumamoto University)
Work history (4):
2002 - 2007 助手
2002 - 2007 Research Associate,
2007 - Kumamoto University University Hospital
2007 - Assistant Professor, ,University Hospital ,Kumamoto University
Association Membership(s) (6):
日本環境感染学会
, 日本化学療法学会
, 日本感染症学会
, 日本エイズ学会
, 日本血液学会
, 日本内科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM